Gary J Latham

USPTO Granted Patents = 17 (Patent Applications = 5)

CIPO Patents = 1

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 144(Granted Patents)

Company Filing History:

Applied Biosystems, LLC

Years Active: 2006-2024

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12139755 - Methods of RNA amplification (2024-11-12),

2. 11236384 - Methods of RNA amplification (2022-02-01),

3. 11214829 - Methods, compositions, kits, and uses for analysis of nucleic acids comprising repeating A/T-rich segments (2022-01-04),

4. 9783848 - PCR methods for characterizing the 5' untranslated region of the FMR1 and FMR2 genes (2017-10-10),

5. 9777330 - mPCR methods for analyzing repeat sequences (2017-10-03),

6. 9464315 - Modified surfaces as solid supports for nucleic acid purification (2016-10-11),

7. 9371560 - Comprehensive FMR1 genotyping (2016-06-21),

8. 8956841 - Recombinant reverse transcriptases (2015-02-17),

9. 8679757 - PCR methods for characterizing the 5' untranslated region of the FMR1 and FMR2 genes (2014-03-25),

10. 8426126 - Modified surfaces as solid supports for nucleic acid purification (2013-04-23),

11. 8409805 - Method of amplification of GC-rich DNA templates (2013-04-02),

12. 8361754 - Recombinant reverse transcriptases (2013-01-29),

13. 8020790 - Biological sample disruption techniques (2011-09-20),

14. 7993831 - Methods of normalization in microRNA detection assays (2011-08-09),

15. 7595179 - Recombinant reverse transcriptases (2009-09-29),

Title: Gary J. Latham: Innovator in RNA Amplification

Introduction: Gary J. Latham, an accomplished inventor based in Austin, TX, has made significant contributions to the field of molecular biology, particularly in RNA amplification technologies. With a portfolio of 17 patents, Latham's work has had a profound impact on how researchers and companies approach RNA analysis and diagnostics.

Latest Patents: Among his recent inventions are groundbreaking methods of RNA amplification, which focus on reverse transcription of cDNA from RNA using a thermostable reverse transcriptase. These innovative methods allow for the linear amplification of RNA templates through multiple cycles of cDNA synthesis, facilitating enhanced precision and efficiency in RNA studies.

Career Highlights: Throughout his career, Gary has been associated with prominent companies in the biotechnology sector, notably Asuragen, Inc. and Applied Biosystems, LLC. His work in these organizations has contributed to transforming approaches to genetic research and diagnostics.

Collaborations: Gary has collaborated with esteemed colleagues, including Liangjing Chen and Robert Setterquist. Their collective expertise has played a crucial role in advancing the methodologies related to RNA amplification and enriching scientific knowledge within the field.

Conclusion: Gary J. Latham stands out as a leading innovator in RNA amplification, exemplified by his 17 patents. His contributions to molecular biology through his inventive techniques continue to influence research and development in this vital area of science, making him a notable figure in the realm of biotechnology innovations.

This text is generated by artificial intelligence and may not be accurate.